Risk groups for severe influenza
The influenza risk groups include people who are more likely than others to develop severe disease if they should be infected. The most recent published ECDC review indicated strong evidence for immunising two large risk groups:
- Older adults
- All persons (over six months of age) with chronic medical conditions
There is no sharp cut-off age for older adults, however many countries use the age of 65 years as a threshold, while other countries use younger ages.
The list of chronic medical conditions in patients often recommended for vaccination in EU/EEA Member States include diseases affecting the:
- respiratory system e.g. asthma
- cardiovascular system e.g. coronary artery disease
- endocrine system e.g. diabetes
- hepatic system e.g. liver cirrhosis
- renal system e.g. chronic renal failure
- neurological/neuromuscular conditions e.g. parkinsonism
In addition to the above:
- any condition compromising respiratory functions e.g. morbid obesity (BMI > 40), physical handicap in children and adults
- immunosuppression due to disease or treatment including due to haematological conditions and HIV infection.
In May 2012, WHO SAGE (Strategic Advisory Group of Experts on immunization) delivered its opinion on seasonal influenza immunisation and published a new Position paper on the use of influenza vaccines in the Weekly Epidemiological Record. This was supported by a background paper that announced a change from the WHO 2005 guidance in declaring a new group, pregnant women, the priority for immunisation above all other groups.
It also added young children to the groups that should be offered immunisation, emphasizing at the same time the importance of immunising the groups mentioned in the 2005 guidance: older people, individuals >6 months of age with chronic conditions, and health care workers with patient contact.
The evidence for and against immunizing pregnant women and children was summarised by ECDC in 2012 in a technical report ECDC scientific advice on seasonal influenza vaccination of children and pregnant women.
ECDC main outputs on the topic
Seasonal influenza vaccination of children and pregnant women (ECDC guidance, published 2012)
The aim of this guidance document is to provide EU/EEA Member States and EU bodies with relevant information to make an informed decision on routine vaccination of healthy children and pregnant women with seasonal influenza vaccine. The options presented in this document are based on a systematic review of the literature and the opinions of a group of independent experts.
Priority risk groups for influenza vaccination (ECDC guidance, published 2008)
This paper identifies and describes population groups at increased risk for severe outcomes of influenza (“risk groups”) and advocates vaccination for two major groups, namely a) persons in the older age group, usually 65 years and older; and b) persons with chronic medical conditions.
See all updates on seasonal influenza vaccination
WHO recommendations for influenza virus vaccine composition for the 2018-2019 Northern hemisphere season
Low uptake of seasonal influenza vaccination in Europe may jeopardise capacity to protect people in next pandemic
WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season
More about immunisation
Immunisation and vaccines
Vaccines represent one of the most effective and cost-saving public health intervention.Read more
Immunisation is a safe and cost-effective way to protect people – especially infants and young children – from certain infectious diseases. All EU countries have a 'vaccination schedule', recommending the vaccines to be given at various ages during childhood. However, too many children in Europe go unvaccinated and remain vulnerable to potentially life-threatening diseases.Read more